Variation in Serum Pepsinogens With Severity and Topography of Helicobacter pylori‐Associated Chronic Gastritis in Dyspeptic Patients Referred for Endoscopy
- 1 September 2001
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 6 (3) , 216-224
- https://doi.org/10.1046/j.1523-5378.2001.00031.x
Abstract
Background.: It has long been recognised that specific patterns of gastritis are linked with different gastroduodenal diseases and that serum pepsinogens vary with the histological state of the gastric mucosa. With the discovery of the role of Helicobacter pylori in chronic gastritis and the availability of noninvasive tests for H. pylori infection, individuals with H. pylori gastritis can now be identified without endoscopic biopsy. However, without a knowledge of the pattern and severity of gastritis it is impossible to predict the likelihood of significant associated gastroduodenal pathology.Aims.: The aim of this study was to evaluate the diagnostic potential of serum pepsinogens I and II in predicting the topography and severity of gastritis in H. pylori‐infected dyspeptic patients attending for endoscopy.Methods.: Fasting serum was obtained from consecutive dyspeptic patients attending for endoscopy, and pairs of gastric biopsies obtained from the mid‐body and antrum. Gastritis was graded according to the Sydney System, and serum pepsinogen levels determined by radio‐immunoassay.Results.: Sixty‐nine dyspeptic patients were studied (mean age: 49.6 years) of whom 34 had H. pylori‐associated chronic gastritis (Hp‐gastritis) – antral predominant gastritis (APG) in 41.2%, pangastritis (PAN) in 52.9%, and corpus predominant (CPG) in 5.9%. Serum pepsinogen II levels were significantly higher, and the serum pepsinogen I : II ratio significantly lower, in the H. pylori positive group than in other groups. Within the Hp‐gastritis group, there was a step‐wise decrease in serum pepsinogen I levels with progression from APG through PAN to CPG pattern (a cut‐off value of ≥ 100 ng/ml would have identified APG with a positive predictive value of 77%, though with low sensitivity). Within the Hp‐gastritis group, serum pepsinogen I and II levels were correlated with antral chronic inflammation score and serum pepsinogen II levels also with antral activity score. Serum pepsinogen I and the pepsinogen I : II ratio were lowest in severe gastric corpus atrophy.Conclusion.: In dyspeptic patients known to be infected with H. pylori, serum pepsinogen values provide an assessment of the overall topography of gastritis, the severity of antral inflammation and the presence of severe corpus atrophy.Keywords
This publication has 18 references indexed in Scilit:
- Helicobacter pyloriand gastric inflammationBritish Medical Bulletin, 1998
- Serological parameters in assessment of degree of gastritis in healthy volunteersDigestive Diseases and Sciences, 1995
- Histopathology of gastroduodenal inflammation: the impact of Helicobacter pyloriHistopathology, 1995
- Serum Pepsinogen I and Serum Gastrin in the Screening of Severe Atrophic Corpus GastritisScandinavian Journal of Gastroenterology, 1991
- Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori.Journal of Clinical Pathology, 1990
- The Ratio of Pepsinogen A to Pepsinogen C: A Sensitive Test for Atrophic GastritisScandinavian Journal of Gastroenterology, 1989
- Clinical significance of pepsinogen a isozymogens, serum pepsinogen A and C levels, and serum gastrin levelsCancer, 1987
- Elevated Serum Pepsinogen I and II Levels Differ as Risk Factors for Duodenal Ulcer and Gastric UlcerGastroenterology, 1986
- Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal HistologyGastroenterology, 1982
- Etiology of Gastric UlcerGastroenterology, 1972